We found that the most clinically relevant biological pathway pinpointed as downregulated by pesticide exposure in breast cancer patients by in silico was the estrogen receptor (ER) signaling, in association with the ESSRA transcription factor. The gene discussed is ESR1; the disease is breast carcinoma.